Evidence map›Paper›PMID 31812181›Full record

ReviewThe Journal of allergy and clinical immunology2019

Food allergy and the microbiome: Current understandings and future directions.

Supinda Bunyavanich, M Cecilia Berin

3 registry-linked trialsAbstract readReview
In one paragraph

Review in The Journal of allergy and clinical immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 103 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04604912 completednot on this map

Multi-omics Endotyping of Food-allergic Patients For Advanced Biomarker Discovery

Typeobservational_patient_registrySponsorLuxembourg Institute of HealthRan2017 to 2023Enrolled74ConditionsAllergy, Food
NCT05138757 phase1 / phase2completednot on this mapstarted 2021, after this paper: background citation

Fiber Supplementation In Children With Peanut Allergy On Oral Immunotherapy: A Randomized Controlled Pilot Study

TypeinterventionalSponsorUniversity of ChicagoRan2021 to 2025Enrolled20ConditionsPeanut AllergyArmsPrebiotic, Placebo
NCT06558526 narecruitingnot on this mapstarted 2025, after this paper: background citation

Analysis of the Clinical Efficacy and Immunomodulatory Effect of Pectin in LTP Allergic Patients Through a Placebo-controlled Intervention Study and Long-term Follow-up

TypeinterventionalSponsorFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludRan2025 to 2026Enrolled62ConditionsFood AllergyArmsApple pectin (DE 57%), Placebo
3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Preventive effect of heat-killed Lactiplantibacillus plantarum FM8 in an ovalbumin-induced food allergy murine model.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Observational
  17. RecombinantFrontiers in immunology · 2026
    Article
  18. Clinical Proteomics Applied to Food Allergy.Advances in experimental medicine and biology · 2026
    Review
  19. Article
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Supinda BunyavanichDivision of Allergy and Immunology, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: supinda@post.harvard.edu.
M Cecilia BerinDivision of Allergy and Immunology, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY; PRIISM Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: cecilia.berin@mssm.edu.

Funding

Threshold, Severity, and Immunotherapy of Peanut AllergyU19AI136053 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BUNYAVANICH, SUPINDA · 2018 to 2023
$9.1M
Nasal biomarkers of asthmaR01AI118833 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BUNYAVANICH, SUPINDA · 2015 to 2019
$3.8M
Gut Microbiome Dynamics in Peanut AllergyR01AI147028 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BUNYAVANICH, SUPINDA · 2019 to 2022
$3.3M
Novel tools to maximize profiling of tissue and antigen specific immune dysregulation in allergy and inflammatory bowel disesaseU24AI118644 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BERIN, CECILIA, MERAD, MIRIAM · 2015 to 2020
$2.4M
NIAID NIH HHS R01 AI118833NIAID NIH HHS R01 AI147028NIAID NIH HHS U19 AI136053NIAID NIH HHS U24 AI118644
6 · The paper itself

Abstract

Growing evidence points to an important role for the commensal microbiota in susceptibility to food allergy. Epidemiologic studies demonstrate associations between exposures known to modify the microbiome and risk of food allergy. Direct profiling of the gut microbiome in human cohort studies has demonstrated that individuals with food allergy have distinct gut microbiomes compared to healthy control subjects, and dysbiosis precedes the development of food allergy. Mechanistic studies in mouse models of food allergy have confirmed that the composition of the intestinal microbiota can imprint susceptibility or resistance to food allergy on the host and have identified a unique population of microbially responsive RORγt-positive FOXp3-positive regulatory T cells as critical for the maintenance of tolerance to foods. Armed with this new understanding of the role of the microbiota in food allergy and tolerance, therapeutics aimed at modifying the gastrointestinal microbiota are in development. In this article we review key milestones in the development of our current understanding of how the gastrointestinal microbiota contributes to food allergy and discuss our vision for the future of the field.

Indexed as

AnimalsDysbiosisFood HypersensitivityHumansImmune ToleranceMiceMicrobiotaT-Lymphocytes, RegulatorydysbiosisFood allergymicrobiomemicrobiotaprebioticprobioticregulatory T cellsshort-chain fatty acidssymbiotic

Identifiers

PMID31812181
PMCPMC6905201

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.